[go: up one dir, main page]

EP2283161A4 - Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet - Google Patents

Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet

Info

Publication number
EP2283161A4
EP2283161A4 EP09747751A EP09747751A EP2283161A4 EP 2283161 A4 EP2283161 A4 EP 2283161A4 EP 09747751 A EP09747751 A EP 09747751A EP 09747751 A EP09747751 A EP 09747751A EP 2283161 A4 EP2283161 A4 EP 2283161A4
Authority
EP
European Patent Office
Prior art keywords
colorectal cancer
compositions therefor
evaluating colorectal
evaluating
therefor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP09747751A
Other languages
German (de)
English (en)
Other versions
EP2283161A2 (fr
Inventor
Mitch Raponi
Greg M Arndt
Lesley Dossey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Diagnostics LLC
Original Assignee
Veridex LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Veridex LLC filed Critical Veridex LLC
Publication of EP2283161A2 publication Critical patent/EP2283161A2/fr
Publication of EP2283161A4 publication Critical patent/EP2283161A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
EP09747751A 2008-05-16 2009-05-18 Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet Withdrawn EP2283161A4 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5376008P 2008-05-16 2008-05-16
PCT/US2009/044282 WO2009140670A2 (fr) 2008-05-16 2009-05-18 Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet

Publications (2)

Publication Number Publication Date
EP2283161A2 EP2283161A2 (fr) 2011-02-16
EP2283161A4 true EP2283161A4 (fr) 2012-03-28

Family

ID=41319374

Family Applications (1)

Application Number Title Priority Date Filing Date
EP09747751A Withdrawn EP2283161A4 (fr) 2008-05-16 2009-05-18 Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet

Country Status (8)

Country Link
EP (1) EP2283161A4 (fr)
JP (1) JP2011520454A (fr)
KR (1) KR20110015013A (fr)
BR (1) BRPI0911972A2 (fr)
CA (1) CA2725477A1 (fr)
IL (1) IL209078A0 (fr)
MX (1) MX2010012542A (fr)
WO (1) WO2009140670A2 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2625293A4 (fr) * 2010-10-08 2014-03-19 Baylor Res Inst Microarn (miarn) en tant que biomarqueurs pour l'identification du cancer colorectal familial et non-familial
US20130331291A1 (en) * 2010-12-01 2013-12-12 Assistance Publique -Hôpitaux De Paris (Aphp) Method for predicting the outcome of colon cancer by analysing mirna expression
EP2778237A1 (fr) * 2011-01-13 2014-09-17 Industrial Technology Research Institute Biomarqueurs de prédiction de la récurrence du cancer colorectal
NO3051026T3 (fr) * 2011-10-21 2018-07-28
JP6156621B2 (ja) * 2012-02-14 2017-07-05 国立大学法人 岡山大学 Ａｔｌｌの診断のためのデータ取得方法、ａｔｌｌ診断用キットおよびａｔｌｌ診断システム
WO2013160474A2 (fr) * 2012-04-26 2013-10-31 Instituto Aragonés De Ciencias De La Salud Expression de miarn dans les maladies hématologiques
WO2015126886A1 (fr) * 2014-02-18 2015-08-27 Baylor Research Institute Mir-320e et cancer colorectal

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059026A1 (fr) * 2007-10-30 2009-05-07 Veridex, Llc Procédé de surveillance du cancer colorectal

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059026A1 (fr) * 2007-10-30 2009-05-07 Veridex, Llc Procédé de surveillance du cancer colorectal

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ARNDT GREG M ET AL: "Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer", BMC CANCER, BIOMED CENTRAL, LONDON, GB, vol. 9, no. 1, 20 October 2009 (2009-10-20), pages 374, XP021062713, ISSN: 1471-2407, DOI: 10.1186/1471-2407-9-374 *
BANDRÉS E ET AL: "Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues", MOLECULAR CANCER, BIOMED CENTRAL, LONDON, GB, vol. 5, 19 July 2006 (2006-07-19), pages 29, XP002460700, ISSN: 1476-4598, DOI: 10.1186/1476-4598-5-29 *
JAY CHRIS ET AL: "miRNA profiling for diagnosis and prognosis of human cancer", DNA AND CELL BIOLOGY, MARY ANN LIEBERT, NEW YORK, NY, US, vol. 26, no. 5, 1 May 2007 (2007-05-01), pages 293 - 300, XP002510058, ISSN: 1044-5498, DOI: 10.1089/DNA.2006.0554 *

Also Published As

Publication number Publication date
MX2010012542A (es) 2010-12-21
WO2009140670A9 (fr) 2010-03-18
EP2283161A2 (fr) 2011-02-16
KR20110015013A (ko) 2011-02-14
WO2009140670A2 (fr) 2009-11-19
CA2725477A1 (fr) 2009-11-19
IL209078A0 (en) 2011-01-31
BRPI0911972A2 (pt) 2019-09-24
JP2011520454A (ja) 2011-07-21

Similar Documents

Publication Publication Date Title
EP2295564A4 (fr) Composition et procédé de détermination du cancer de l' sophage
EP2295970A4 (fr) Analyseur permettant de procéder à des immunodosages et procédé d'immunodosage
CY2019005I1 (el) Συνθεσεις και μεθοδοι για την αναστολη εκφρασης τρανσθυρετινης
EP2029049A4 (fr) Procédés et compositions pour réparation tissulaire
EP2231257A4 (fr) Procédé d'application
HRP20170347T1 (hr) Pripravci i postupci za uporabu za protutijela protiv sklerostina
EP2194781A4 (fr) Compositions et procédés permettant d'améliorer la fonction cognitive
EP2209414A4 (fr) Procédé de réalisation de tests d'acuité visuelle
DK2084519T3 (da) Røntgenfluorescens-analysefremgangsmåde
EP2010225A4 (fr) Procédés et compositions destinés à cibler le c-rel
EP2344660A4 (fr) Procédés et compositions pour inactiver l'expression du gène de la glutamine synthétase
EP2086318A4 (fr) Compositions neuroprotectrices et procédés correspondants
EP2067348A4 (fr) Procédé d'enregistrement de conversation variable
EP1897940A4 (fr) Composition et procédé permettant de diagnostiquer un cancer oesophagien et une métastase d'un cancer oesophagien
EP2024509A4 (fr) Procédé de détection
EP2283161A4 (fr) Procédé d'évaluation du cancer colorectal et compositions utilisables à cet effet
EP2207037A4 (fr) Procédé de détection d'un cancer
ZA200806771B (en) Method for analyzing hair
ATE526567T1 (de) Zusammensteller und zusammenstellungsverfahren
EP2173382A4 (fr) Composition de réparation de blessure et procédé
EP2068618A4 (fr) Compositions et procédés permettant de rechercher des gènes du cancer
EP2152945A4 (fr) Procédé de décortication
EP2093667A4 (fr) Procédé de compilation et compilateur
DE602007001706D1 (de) Tonerzusammensetzung und Verfahren
EP2061498A4 (fr) Compositions et procédés de prévention du cancer avec des cupredoxines

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20101216

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA RS

RAX Requested extension states of the european patent have changed

Extension state: AL

Payment date: 20101216

A4 Supplementary search report drawn up and despatched

Effective date: 20120223

RIC1 Information provided on ipc code assigned before grant

Ipc: C12Q 1/68 20060101AFI20120217BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120925